In patients with chronic viral hepatitis B, if there are positive hepatitis B surface antigen, positive hepatitis B E antibody and positive hepatitis B core antibody in the hepatitis B triple system, the patient has a small triple-positive condition, and the virus in the patient’s body is not replicating. If the patient has a blood test for hepatitis B DNA at this time, it mostly indicates that the patient has a low viral load. In addition, if the patient’s liver function is normal, it is recommended that the patient continue to observe can, usually pay attention to do not drink alcohol, do not stay up late, do not strain, maintain the body’s self-immunity, the patient’s condition will be in a stable state. However, patients should regularly review the hepatitis B triple system, hepatitis B DNA and liver function to see if they will turn into major triple yang or have viral replication. If, at a later stage, the patient has replication of the virus and has elevated glutathione and glutamic acid aminotransferase in the liver function, further liver preservation therapy and antiviral therapy should be actively considered. Anti-viral treatment can choose oral drugs, such as lamivudine, entecavir, etc., and can also choose to inject interferon for active treatment.